REICH, K.; BLAUVELT, A.; THACI, D.; LEONARDI, C.; POULIN, Y.; BURGE, D.; PETERSON, L.; ARENDT, C.; GOTTLIEB, A. B. Maintenance of Response with Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: 48-Week Results from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s23, 2017. DOI: 10.25251/skin.1.supp.22. Disponível em: https://www.jofskin.org/index.php/skin/article/view/125. Acesso em: 16 may. 2022.